AN2 Therapeutics, Inc

Kalaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company based in Palo Alto, California, focused on developing innovative treatments for prevalent retinal diseases. Founded by experienced leaders in ophthalmology, the company aims to address significant unmet needs by creating therapies that ease the burden on patients and caregivers while improving treatment outcomes. The company's lead product, TH103, is a fully humanized recombinant fusion protein designed for intravitreal delivery, demonstrating potential as a best-in-class anti-VEGF agent. With an experienced management team and support from veteran investors, Kalaris is currently evaluating TH103 in a Phase 1 clinical trial for neovascular age-related macular degeneration, with plans to expand its application to other neovascular and exudative retinal diseases. Generated from the website

LIPAC Oncology is a clinical-stage company based in Menlo Park, California, specializing in the development of precision targeted, locally delivered taxane technology for the treatment of various types of cancer, including Bladder Cancer, Upper Tract Urothelial Carcinoma, Stage II III Ovarian Cancer, Intraperitoneal Carcinoma, and Mesothelioma Malignant Pleural Effusion. With a strong focus on addressing areas of significant unmet medical need, LIPAC Oncology's innovative pipeline of products aims to provide life-saving treatment options for cancer patients through breakthrough nano liposome-bound technology, offering localized tumor treatment.Generated from the website

Antheia Inc, based in Menlo Park, CA, is a leading biotechnology company specializing in fermentation and synthetic biology. With a strong focus on innovation and research, Antheia develops comprehensive fermentation processes and data collection systems, led by their experienced team of experts in microbial metabolism and fermentation process development. Under the leadership of their Head of Strategy, Partnerships, and Finance, Antheia also collaborates with various organizations to establish global standards for AI in healthcare. Additionally, their Biology team, headed by an industry veteran, specializes in strain and protein engineering, while their Downstream Processing division is led by an expert in the field. Antheia is dedicated to advancing the field of biotechnology through cutting-edge research and development.Generated from the website